NTR — Nutrien Ltd.

Nutrien Q3 2025 Earnings Call Summary

1. Key Financial Results and Metrics

• Adjusted EBITDA: $1.4 billion for Q3 2025, a 42% increase year-over-year.
• Potash Adjusted EBITDA: $733 million, driven by higher net selling prices and record sales volumes.
• Nitrogen Adjusted EBITDA: $556 million, reflecting higher prices and sales volumes.
• Phosphate Adjusted EBITDA: $122 million, benefiting from price increases despite higher sulfur costs.
• Retail Adjusted EBITDA: $230 million, up 52% from the previous year.
• Year-to-Date Capital Expenditures: Reduced by 10% to $2 billion, with a target of $2.0 to $2.1 billion for the full year.
• Shareholder Returns: $1.2 billion allocated to dividends and share repurchases, a 42% increase from the previous year.

2. Strategic Updates and Business Highlights

• Sales Volumes: Increased by approximately 750,000 tonnes year-over-year, with record potash sales volumes.
• Cost Reduction Initiatives: On track to achieve a $200 million cost reduction target one year ahead of schedule, with a 5% reduction in SG&A expenses.
• Divestitures: Completed or agreed upon sales of noncore assets expected to generate approximately $900 million in gross proceeds.
• Phosphate Business Review: Initiated a strategic review to evaluate alternatives for the phosphate business, including potential reconfiguration, partnerships, or sale.
• Trinidad Operations: Controlled shutdown due to supply issues; contributes less than 1% of free cash flow.

3. Forward Guidance and Outlook

• Potash Shipment Projections: Increased to a record 73 million to 75 million tonnes for 2025, with expectations for continued demand growth in 2026 (74 million to 77 million tonnes).
• Nitrogen Market Outlook: Anticipated tight supply and demand balance into 2026, with seasonal demand expected to tighten urea market fundamentals.
• Retail Business Guidance: Adjusted EBITDA guidance narrowed to $1.68 billion to $1.82 billion for the full year, with expectations for slightly higher North American crop nutrient volumes in Q4.

4. Bad News, Challenges, or Points of Concern

• Trinidad Operations: The shutdown raises concerns about long-term operational viability and contribution to cash flow.
• Phosphate Business: Contributes only 6% of EBITDA, prompting a strategic review due to its underperformance relative to other segments.
• Market Uncertainty: Potential demand deferrals in phosphate and potash due to economic pressures on farmers, though overall demand is expected to remain stable.
• Cost Pressures: Increased turnaround costs and lower planned potash production have slightly raised controllable cash costs.

5. Notable Q&A Insights

• Phosphate Business Review: Management emphasized the need for a strategic review to enhance cash flow and earnings quality, considering various operational adjustments and potential partnerships.
• Trinidad Asset Future: Management is focused on finding a reliable gas supply and port access, with no immediate plans for divestiture but keeping options open.
• Retail Business Dynamics: Strong crop input demand is expected to continue, although some competitors are experiencing demand deferrals.
• Capital Allocation Strategy: Nutrien remains committed to maintaining a balanced approach to capital allocation, prioritizing debt reduction while continuing share repurchases and dividends.

Overall, Nutrien's Q3 2025 results reflect strong operational performance and strategic progress, although challenges remain in specific segments like phosphate and Trinidad operations. The company maintains a positive outlook for potash and nitrogen markets, supported by robust demand fundamentals.